dipropylacetamide has been researched along with carbamazepine epoxide in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eugster, HP; Hinnen, A; Meyer, UA; Sengstag, C; Würgler, FE | 1 |
Eddy, AC; Guyot, M; Kerr, BM; Levy, RH; Loiseau, P; Rettie, AE; Wilensky, AJ | 1 |
Bertilsson, L; Fazio, A; Oteri, G; Perucca, E; Pisani, F; Spina, E | 1 |
Binnie, CD; de Beer-Pawlikowski, NK; Debets, RM; Meijer, JW; van Parys, JA | 1 |
Eugster, HP; Sengstag, C | 1 |
5 other study(ies) available for dipropylacetamide and carbamazepine epoxide
Article | Year |
---|---|
Heterologous expression of human microsomal epoxide hydrolase in Saccharomyces cerevisiae. Study of the valpromide-carbamazepine epoxide interaction.
Topics: Base Sequence; Carbamazepine; Drug Interactions; Epoxide Hydrolases; Epoxy Compounds; Gene Expression Regulation, Enzymologic; Humans; Kinetics; Microsomes; Molecular Sequence Data; Saccharomyces cerevisiae; Styrenes; Valproic Acid | 1991 |
Inhibition of human liver microsomal epoxide hydrolase by valproate and valpromide: in vitro/in vivo correlation.
Topics: Anticonvulsants; Carbamazepine; Drug Interactions; Epoxide Hydrolases; Epoxy Compounds; Humans; Hydrolysis; In Vitro Techniques; Male; Microsomes, Liver; Valproic Acid | 1989 |
Effect of valpromide on the pharmacokinetics of carbamazepine-10, 11-epoxide.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Female; Half-Life; Humans; Male; Middle Aged; Valproic Acid | 1988 |
Possible hazard of valpromide-carbamazepine combination therapy in epilepsy.
Topics: Anticonvulsants; Carbamazepine; Drug Synergism; Drug Therapy, Combination; Epilepsy; Humans; Valproic Acid | 1984 |
Saccharomyces cerevisiae: an alternative source for human microsomal liver enzymes and its use in drug interaction studies.
Topics: Anticonvulsants; Benzoflavones; Carbamazepine; Cloning, Molecular; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; DNA, Complementary; Drug Interactions; Epoxide Hydrolases; Humans; Ketoconazole; Microsomes, Liver; Oxidoreductases, N-Demethylating; Saccharomyces cerevisiae; Valproic Acid | 1993 |